According to our (Global Info Research) latest study, the global Biological Dura Patch market size was valued at US$ 695 million in 2025 and is forecast to a readjusted size of US$ 1030 million by 2032 with a CAGR of 5.8% during review period.
In 2024, global biological dura patch production reached approximately 1,557 K pieces, with an average global market price of around US$ 412 per piece.
Biological dura patches are surgical repair materials made from animal tissues, such as bovine or porcine collagen. These patches are primarily used in neurosurgery to repair the dura mater and promote tissue healing by mimicking the natural structure of the dura. Biological dura patches are known for their high biocompatibility and ease of use in various surgical applications.
The biological dura patch market is driven by both evolving clinical practice and advances in materials science. As neurosurgery shifts toward minimally invasive, endoscopic, and personalized approaches, surgeons increasingly favor materials that both reliably seal cerebrospinal fluid leaks and integrate into host tissue. Biological patches—owing to natural adhesion sites and their capacity to support matrix remodeling—are often preferred in scenarios where eventual tissue incorporation and reduced chronic foreign-body response are priorities. Differences in source material (allograft vs xenograft) and processing determine degradation profiles, mechanical strength, and immunocompatibility, making these attributes key points of product differentiation.
From a commercialization perspective, regulatory compliance and clinical evidence are central to market entry. Hospitals in more developed healthcare systems prioritize brands with long-term follow-up data and robust technical support; for many manufacturers, investing in clinical trials to demonstrate safety and efficacy is essential to gain trust and access premium segments. Supply chain factors—traceable raw materials, validated sterilization, and consistent production capacity—also heavily influence procurement and regional adoption. Cost-sensitive regions may favor more economical product tiers, prompting companies to adopt multi-tier strategies.
Future growth will come from combined advances: biofunctional modifications that better control resorption and direct cellular responses, composite patches that integrate hemostatic or antimicrobial functions, and geometries optimized for minimally invasive or endoscopic deployment. In parallel, customization enabled by imaging and surgical planning tools will open avenues for patient-specific patches. Despite technological progress, demonstrated long-term biocompatibility, immune response management, and systematic clinical evidence will remain the decisive factors for broad clinical adoption.
This report is a detailed and comprehensive analysis for global Biological Dura Patch market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Biological Dura Patch market size and forecasts, in consumption value ($ Million), sales quantity (K Pieces), and average selling prices (USD/Piece), 2021-2032
Global Biological Dura Patch market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Pieces), and average selling prices (USD/Piece), 2021-2032
Global Biological Dura Patch market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Pieces), and average selling prices (USD/Piece), 2021-2032
Global Biological Dura Patch market shares of main players, shipments in revenue ($ Million), sales quantity (K Pieces), and ASP (USD/Piece), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biological Dura Patch
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biological Dura Patch market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Integra LifeSciences, B. Braun, Tianxinfu Medical Appliance, Medtronic, Baxter, Zhenghai Bio-Tech, Guanhao Biotech, Regenity, Cook Medical, Balance Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Biological Dura Patch market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Bovine Derived Materials
Porcine Derived Materials
Market segment by Application
Public Hospital
Private Hospital
Major players covered
Integra LifeSciences
B. Braun
Tianxinfu Medical Appliance
Medtronic
Baxter
Zhenghai Bio-Tech
Guanhao Biotech
Regenity
Cook Medical
Balance Medical
YH Biomax
Bonsci Technology
Biosis Healing Biological
Cingular Biotechnology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biological Dura Patch product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Biological Dura Patch, with price, sales quantity, revenue, and global market share of Biological Dura Patch from 2021 to 2026.
Chapter 3, the Biological Dura Patch competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biological Dura Patch breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Biological Dura Patch market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Biological Dura Patch.
Chapter 14 and 15, to describe Biological Dura Patch sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Biological Dura Patch. Industry analysis & Market Report on Biological Dura Patch is a syndicated market report, published as Global Biological Dura Patch Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Biological Dura Patch market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.